Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lilly's US Bamlanivimab Contract Raises Difficult Allocation Considerations
Oct 28 2020
•
By
Jessica Merrill
Availability of Lilly's antibody for COVID-19 will be limited • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access